These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37271212)
1. Pretherapy Cheng MF; Guo YL; Yen RF; Wu YW; Wang HP Korean J Radiol; 2023 Jun; 24(6):590-598. PubMed ID: 37271212 [TBL] [Abstract][Full Text] [Related]
2. Semiquantitative An SY; Sun BJ BMC Cardiovasc Disord; 2024 Feb; 24(1):122. PubMed ID: 38389040 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638 [TBL] [Abstract][Full Text] [Related]
4. Clinical value of Bai Z; Zhou T; Yu Z; Chen Y; Dong L Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418 [TBL] [Abstract][Full Text] [Related]
14. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease. Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437 [TBL] [Abstract][Full Text] [Related]
16. 18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review. Dondi F; Albano D; Bellini P; Volpi G; Giubbini R; Bertagna F Nucl Med Commun; 2022 Jun; 43(6):638-645. PubMed ID: 35438679 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast Activation Protein-Targeted PET/CT with Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902 [TBL] [Abstract][Full Text] [Related]
18. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization. Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease. Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750 [TBL] [Abstract][Full Text] [Related]
20. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]